SMS Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 6 March 2024 .Powered by Capital Market - Live News

Net profit of SMS Pharmaceuticals rose 205.32% to Rs 11.48 crore in the quarter ended December 2023 as against Rs 3.76 crore during the previous quarter ended December 2022. Sales rose 8.52% to Rs 161.48 crore in the quarter ended December 2023 as against Rs 148.80 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales161.48148.80 9 OPM %17.9612.45 - PBDT24.5414.79 66 PBT16.536.67 148 NP11.483.76 205 Powered by Capital Market - Live News

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 February 2024.Powered by Capital Market - Live News

Net profit of SMS Pharmaceuticals reported to Rs 11.73 crore in the quarter ended September 2023 as against net loss of Rs 2.01 crore during the previous quarter ended September 2022. Sales rose 4.52% to Rs 166.64 crore in the quarter ended September 2023 as against Rs 159.43 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales166.64159.43 5 OPM %16.698.51 - PBDT23.068.93 158 PBT15.160.84 1705 NP11.73-2.01 LP Powered by Capital Market - Live News

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 November 2023.Powered by Capital Market - Live News